Crewe Advisors’s Apellis Pharmaceuticals APLS Stock Holding History

Crewe Advisors’s Portfolio APLS Stock Details APLS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	$1.99K	Buy
2024 Q1	–	Sell
2023 Q4	$240	Hold
2023 Q3	$153	Buy